Ken Griffin (Citadel Advisors) add BioMarin Pharmaceutical Inc.
Ken Griffin (Citadel Advisors) add $165.8M of disclosed value in BioMarin Pharmaceutical Inc..
Signal
Investor Move
Action
Add
Capital
$165.8M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.